Cargando…
Isotretinoin-Induced Delusional Disorder, Somatic Subtype
Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusiona...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399729/ https://www.ncbi.nlm.nih.gov/pubmed/32774942 http://dx.doi.org/10.1155/2020/8853167 |
_version_ | 1783566198944825344 |
---|---|
author | Jensen, Katharine V. Abba-Aji, Adam |
author_facet | Jensen, Katharine V. Abba-Aji, Adam |
author_sort | Jensen, Katharine V. |
collection | PubMed |
description | Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness. The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day. Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine. |
format | Online Article Text |
id | pubmed-7399729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-73997292020-08-07 Isotretinoin-Induced Delusional Disorder, Somatic Subtype Jensen, Katharine V. Abba-Aji, Adam Case Rep Dermatol Med Case Report Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness. The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day. Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine. Hindawi 2020-07-25 /pmc/articles/PMC7399729/ /pubmed/32774942 http://dx.doi.org/10.1155/2020/8853167 Text en Copyright © 2020 Katharine V. Jensen and Adam Abba-Aji. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Jensen, Katharine V. Abba-Aji, Adam Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title | Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title_full | Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title_fullStr | Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title_full_unstemmed | Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title_short | Isotretinoin-Induced Delusional Disorder, Somatic Subtype |
title_sort | isotretinoin-induced delusional disorder, somatic subtype |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399729/ https://www.ncbi.nlm.nih.gov/pubmed/32774942 http://dx.doi.org/10.1155/2020/8853167 |
work_keys_str_mv | AT jensenkatharinev isotretinoininduceddelusionaldisordersomaticsubtype AT abbaajiadam isotretinoininduceddelusionaldisordersomaticsubtype |